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Streptococcus pyogenes expresses the LPXTG 
motif-containing cell-envelope serine protease 
SpyCep (also called ScpC, PrtS) that degrades 
and inactivates the major chemoattractant 
interleukin 8 (IL-8), thereby impairing host 
neutrophil recruitment. In this study we 
identified a novel function of SpyCep: the 
ability to mediate uptake into primary human 
endothelial cells (HUVEC). SpyCep triggered 
its uptake into endothelial cells but not into 
human epithelial cells originating from 
pharynx or lung, indicating an endothelial cell-
specific uptake mechanism. SpyCep mediated 
cellular invasion by an endosomal/lysosomal 
pathway distinct from the caveolae-mediated 
invasion pathway of S. pyogenes. Recombinant 
expression and purification of proteolytically 
active SpyCep and a series of sub-fragments 
allowed functional dissection of the domains 
responsible for endothelial cell invasion and 
IL-8 degradation. The N-terminal PR-domain 
was sufficient to mediate endothelial cell 
invasion, whereas for IL-8 degrading activity 
the PR-domain and the flanking A domain was 
required. A polyclonal rabbit serum raised 
against the recombinant protease efficiently 
blocked the invasion-mediating activity of 
SpyCep, but not its proteolytic function, further 
indicating that SpyCep-mediated interna-
lization is independent from its enzymatic 
activity.  SpyCep may thus specifically mediate 
its own uptake as secreted protein into human 
endothelial cells. 
Streptococcus pyogenes is an important human 
pathogen able to cause infections ranging from 
mild pharyngitis to severe invasive disease. 
Necrotizing fasciitis and other life-threatening S. 
pyogenes infections are increasingly reported 
during recent decades and large efforts have been 
undertaken to identify virulence factors that play a 
role in their development. A genome-wide analysis 
of the transcriptome of invasive vs. noninvasive 
serotype M1T1 S. pyogenes strains revealed a 
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 frame shift mutation in the global transcriptional 
regulator sensor gene covS among the invasive 
strains, resulting in the up-regulation of several 
putative or known virulence factors (1). One such 
virulence factor was SpyCep (ScpC, PrtS), a 
subtilisin type serine protease, whose encoding 
mRNA was more than 10-fold more abundant in 
the invasive transcriptome. SpyCep is a 1647 
amino acid protein and predicted to be secreted 
and covalently linked to the streptococcal cell 
wall via a C-terminal LP(X)TG motif. The 
enzyme shares the overall multi-domain 
organization of cell-envelope proteases (Cep) of 
lactic acid bacteria, consisting of a pre-pro-
domain for Sec-dependent secretion and 
autocatalytic activation, the PR-domain for 
catalytic activity, and the subsequent A and B/H 
domains of yet undefined function (2).  
Two independent studies identified SpyCep as 
the key enzyme for IL-8 degradation and impaired 
neutrophil recruitment (3, 4). The IL-8 degrading 
enzyme was first isolated from culture supernatant 
of an invasive M81 isolate. Using this purified 
enzyme, cleavage of IL-8 between amino acid 
residue 59 and 60 rendered this major human 
chemoattractant functionally inactive (3). 
Subsequently, studies conducted with a highly 
invasive M14 isolate and a set of isogenic 
knockout mutants revealed that SpyCep not only 
degrades the human CXC motif-containing 
chemokine IL-8 but also the murine chemokines 
KC and MIP-2 (4). A recent study focused on the 
role of SpyCep in the globally-disseminated 
M1T1 S. pyogenes clone that has emerged as the 
leading cause of invasive infections during recent 
epidemiology (5). Using a SpyCep knockout 
mutant as well as a Lactococcus lactis strain that 
expressed heterologous SpyCep, it could be 
demonstrated that SpyCep was necessary and 
sufficient to impede IL-8 dependent neutrophil 
endothelial transmigration and also exerted a 
strong inhibitory effect on neutrophil bacterial 
killing and extracellular trap formation (5). 
The gene encoding SpyCep is present in S. 
pyogenes strains of all serotypes, but expression 
levels may vary to a large extent. Mutation events 
such as those affecting SilCR, which encodes a 
regulatory peptide inhibiting SpyCep activity, or 
CovRS, appear to be responsible for the emergence 
of highly aggressive strains (1, 6, 7, 8). 
Since SpyCep plays a central role in invasive 
streptococcal disease by impairing neutrophil 
recruitment across the vascular endothelium, the 
endothelial cell represents an important part of the 
natural environment of SpyCep expression. We 
thus sought to further characterize the biological 
function of SpyCep by analyzing its interaction 
with endothelial cells. We were able to clone, 
express and purify full length recombinant SpyCep 
in its enzymatically active form. SpyCep was 
found to mediate its uptake into endothelial cells 
via an endosomal/lysosomal pathway. Dissection 
of the functional domains revealed that the SpyCep 
N-terminal PR domain mediated uptake into 
endothelial cells whereas the PR+A domain was 
required for IL-8 degrading activity.  
 
EXPERIMENTAL PROCEDURES 
Bacterial strains and culture conditions - S. 
pyogenes strains were grown overnight in THY 
medium. The invasive M14 S. pyogenes strain 
JS95 as well as its isogenic SpyCep deletion 
mutant  JS95 ∆scpC/∆scpA were described earlier 
(4). The S. pyogenes strain A475 is an invasive 
serotype M3 isolate, the SpyCep mutant strain 
A475 ∆SpyCep was grown in the presence of 80 
µg/ml spectinomycin. Streptococcus agalactiae  
serotype Ia strain 102 served as recipient for the 
vector pDCerm or the SpyCep expressing plasmid 
pcepA which were described previously (5). 
 
Cloning, expression and purification of SpyCep 
from E. coli - For expression of the full length 
mature form of SpyCep (rSpyCep, ranging from aa 
111-1560 according to accession no. 
ABA33824.1), excluding the N-terminal pre-pro 
domain and the C-terminal cell wall-anchoring 
domain, a DNA fragment spanning nucleotide 658-
5008 of the scpC gene (accession no. DQ192030) 
was amplified. Primers for amplification (Expand 
High Fidelity PCR System) were: rSpyCep fwd: 
5’-GCTAATTCATGACTGATGCGACTCAA-3’, 
and rSpyCep rev: 5’-TTCATTGGATCC-
GGTATTCACCTTTG-3’. Following digestion 
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 with BspHI and BamHI, the amplicon was cloned 
into the NcoI/BamHI digested vector pQE-60 
(Qiagen) using standard cloning procedures. For 
cloning and expression of SpyCep sub-domains 
PR (spanning aa 111-685) and PR+A (spanning aa 
111-1125), the following reverse primers were 
used in combination with the above listed forward 
primer: PR rev: 5’-CCGCTGGATCCAGCTCCG-
TCAATATT-3’, and PR+A rev: 5’-CGGATC-
CTTGTGGTGGTAGGTGATCTCCT-3’. The 
resulting constructs expressed polypeptides with a 
C-terminal histidine tag that allowed purification 
using Ni-NTA agarose under native conditions 
according to standard procedures (Qiagen). The 
SpyCep A-domain ranging from aa 691-1127 
(according to accession no. ABA33824.1), and the 
A+B/H-domain, ranging from aa 691-1560 were 
expressed as recombinant fusion proteins tagged 
with glutathione S-transferase (GST). DNA 
fragments were amplified with the following 
primers: A domain fwd: 5’-
CGGGATCCTATGTGACAGGAAAAGAC-3’; 
A-domain rev: 5’-CCGGAATTCTCATGTTTGT-
GGTAGGTGATC -3’, A+B/H-domain rev 5’-
CGGGAATTCTCAGGTATTCACCTTTGTGTT 
-3’, and cloned into pGEX-6P-1 according to 
standard cloning procedures. Expression of GST-
tagged SpyCep polypeptides and subsequent 
purification using glutathione sepharose affinity 
chromatography was conducted according to the 
manufacturer’s protocol. 
 
Construction of a SpyCep knock out mutant in 
S. pyogenes A475 - An allelic exchange strategy 
(9) was used to create a SpyCep deletion mutant 
in the serotype M3 strain S. pyogenes A475. 
Briefly, a 514 bp fragment of the 5’ region of the 
scpC  gene ranging from nucleotide 47 to 561 was 
amplified using primers scpC1 (5’-
CGTTTTCGGTCTTA-ATAGGAAGCG-3‘) and 
scpC3 (5‘-CCGGGCAATTGCCGGGATTAAT-
ACCGGCGGCTTTTTGG-3‘), and a 535 bp 
fragment of the 3‘ region was amplified ranging 
from nucleotide 1625 to 2160 using primes scpC2 
(5‘- AACAGTCACATCAAACGTCATCG-3‘) 
and  scpC4 (5‘-GCCGCGCCTAGGCGCACGA-
ATTTGGTAAGGCCATGTC-3‘). In addition, the 
spectinomycin resistance cassette (spc) was 
amplified using primers spc1 (5‘-
CCCGGCAATTGCCCGGATCGATTTTCGTTC
GTGAAT-3‘) and spc2 (5‘-GCGCCTAGGCGC-
GGCCCAATTAGAATGAATATTTCCC-3). All 
three PCR fragments were used as templates in a 
single PCR based overlap-extension reaction using 
primes scpC1 and scpC2. The resulting PCR 
product, consisting of the spc-cassette and flanking 
scpC regions, was cloned into vector  pCR2.1 
using the TA-cloning kit (Invitrogen). After 
cleavage with BamHI/XhoI the insert was cloned 
into the temperature sensitive shuttle vector 
pJRS233 (9), resulting in plasmid pCEP-KO. S. 
pyogenes A475 was transformed with pCEP-KO 
by electroporation and transformants were selected 
on THY medium containing 1 µg/ml erythromycin 
at 30°C to allow plasmid replication. Integration of 
the plasmid into the chromosome was selected for 
by a temperature shift to 37°C. The obtained 
clones were tested for double cross over, leading to 
the replacement of an internal scpC fragment 
through the spc cassette and a loss-of-function of 
SpyCep in the deletion mutant. 
  
Reagents and antibodies – Polyclonal 
antibodies recognizing S. pyogenes (anti-GAS) 
were produced in rabbit as described previously 
(10). A mouse monoclonal antibody recognizing a 
luminal epitope of human Lamp-1 (clone H4A3) 
was purchased from Pharmingen (San Diego, 
USA). Secondary goat anti-rabbit IgG antibodies 
coupled to Alexa Fluor® 488/568, and goat anti-
mouse IgG coupled to Alexa Fluor® 488 were 
obtained from Invitrogen (Göttingen, Germany). 
To raise antibodies against recombinant full-length 
SpyCep a rabbit was immunized four times with 
100 µg of rSpyCep per dose at one week intervals 
and serum was collected 2 weeks after the final 
immunization. For purification of anti-SpyCep IgG 
antibodies from serum, a column was packed with 
protein-A sepharose CL-4B and equilibrated with 
0.1 M potassium phosphate buffer (pH 7.0). Then, 
2 ml of rabbit immune serum were applied to the 
column. The column was washed with PBS and 
bound IgG was eluted using 0.1 M glycine/HCl 
(pH 3.0). The elutuate was neutralized by adding 
50 µl of Tris-HCl (pH 8.0) to 1 ml elutuate. IgG 
containing fractions were pooled, dialyzed against 
PBS for 16 h and stored at -20°C. 
 
 
3
 at H
auptbibliothek U
niversitaet Zuerich Irchel. Bereich Forschung on M
arch 10, 2014
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
  
Enzyme-linked immunosorbent assay (ELISA) - 
Streptococci were grown to mid-exponential 
phase at 37°C, collected by centrifugation and the 
pellet was washed twice with PBS and then 
resuspended in Dulbecco’s Modified Essential 
Medium (DMEM; PAA Laboratories) 
supplemented with 0.1% fetal bovine serum 
(FBS) and incubated overnight at 37°C. After 
centrifugation of the culture the supernatant was 
transferred to a 15 ml tube and filtered using a 
filter with 0.2 µm pore size. 50 µl of the 
supernatant were diluted to a final volume of 100 
µl with PBS and 10 ng of IL-8 were added. For 
testing the activity of recombinant proteins, 5 µg 
of recombinant protein were added to 10 ng of 
recombinant IL-8, and PBS was added to give a 
final volume of 100 µl. The reaction mixture was 
incubated for 16-18 h at 37°C. The amount of 
residual interleukin-8 was measured by ELISA 
using the human IL-8 Quantikine ELISA kit 
(R&D) according to the manufacturer’s 
instructions. The absorption was measured at 450 
nm using an ELISA-Reader (Tecan Sunrise). For 
inhibition assays, the culture supernatant of S. 
pyogenes or rSpyCep were incubated with 
affinity-purified anti-SpyCep IgG (50 µg/ml) for 1 
h at 20°C and then co-incubated with recombinant 
IL-8 at 37°C for 16 h. The residual IL-8 was 
measured by ELISA as described above.  
 
Preparation of SpyCep-coated polystyrene 
beads - For coating polystyrene beads with 
SpyCep, approximately 107 beads (3 µm and 1 µm 
diameter; Sigma) were washed three times in PBS 
and then coated overnight at 4°C with 100 µg/ml 
of the recombinant mature full length SpyCep 
(rSpyCep) or fusion protein constructs containing 
defined domains of SpyCep (PR, PR+A, and 
A+B/H). Affinity-purified recombinant GST 
served as a negative control. Protein coated beads 
were washed three times with PBS, collected by 
centrifugation at 2500 rpm, and finally 
resuspended in EGM2 medium supplemented 
with 2% fetal calf serum (FCS). The coupling 
efficiency of recombinant protein on beads was 
analyzed by SDS-PAGE. Briefly, protein was 
eluted from beads by suspending beads in SDS-
PAGE loading buffer and boiling for 5 min. 
Polypeptides were separated by SDS-PAGE and 
the amount of protein was determined by 
coomassie staining of the gel. The IL-8 degrading 
activity of beads-coupled SpyCep was determined 
via the IL-8 Quantikine ELISA kit according to 
manufacturer’s instructions.  
Endothelial Cell Culture and Internalization 
Assay - Primary human large vascular endothelial 
cells (HUVEC) isolated from umbilical cord were 
purchased from PromoCell (Heidelberg, 
Germany). Endothelial cells were cultured and 
propagated with a maximum of 3 passages in 
EGM-2 medium (PromoCell) according to the 
supplier´s protocol in a cell incubator at 37°C and 
5% CO2. Cells were seeded on coverslips in multi-
well plates (Nunc, Roskilde, Denmark) and grown 
to 75% confluency. SpyCep-coated polystyrene 
beads or SpyCep-coated gold particles were 
suspended in prewarmed EGM-2 medium and 
added to endothelial cells with a multiplicity of 
infection of 100 or 1000, respectively. 
Alternatively, 107 cfu of SpyCep expressing 
Streptococcus agalactiae (GBS-SpyCep) or S. 
agalactiae containing the vector (GBS-pDCerm) 
were added per well. Incubation was stopped by 
washing the monolayer with EGM-2 medium and 
fixing with PBS containing 4% paraformaldehyde. 
Distinct time points for fixation were used for 
monitoring early entry (60-120 min post infection) 
or subsequent trafficking (120-240 min post 
infection), respectively.  
 
Immunofluorescence and Confocal Microscopy 
– Endothelial cells that were co-incubated with 
SpyCep-coated beads were fixed as described 
above and samples were blocked for 30 min with 
PBS containing 10% FCS. Extra-cellular adherent 
SpyCep-coated beads were visualized using rabbit 
polyclonal anti-SpyCep IgG and anti-rabbit Alexa 
Fluor® 488 conjugated IgG. Following 
permeabilization with 0.01% Triton X-100, extra- 
and intra-cellular beads were detected by 
incubation with anti-SpyCep IgG, followed by an 
Alexa Fluor® 568 conjugated anti-rabbit antibody. 
According to their respective label, intra-cellular 
beads appear red and extra-cellular yellow to 
green. For visualization of F-actin, cells were 
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 permeabilized and F-actin was stained with 
phalloidin Alexa Fluor® 488 for 30 min at room 
temperature. For early endosomal antigen 1 
(EEA1) staining, all incubation steps were 
performed in 0.05% (w/v) Saponin/PBS. Anti-
EEA1 (mouse clone 14, BD Biosciences) 
monoclonal antibody was used 1:25. The bound 
primary antibodies were visualized with Alexa 
Fluor® 568-conjugated goat anti-mouse IgG. For 
Lamp-1 analysis, cells were permeabilized and 
labeled with a mouse anti-human Lamp-1 
antibody and a respective anti-mouse Alexa 
Fluor® 488 secondary antibody as described (11). 
Endothelial cells that were infected with 
recombinant S. agalactiae strains were fixed and 
stained for extra- and intra-cellular bacteria using 
a polyclonal mouse anti-GBS antibody (Acris 
Antibodies, Herford, Germany) in combination 
with an anti-rabbit  Alexa Fluor® 488 or Alexa 
Fluor® 568 labeled secondary antibody, 
respectively. Coverslips were mounted on glass 
slides using ProLong® Gold anti-fade reagent 
(Molecular Probes). Mounted samples were 
examined using a Zeiss LSM 510 Meta (Zeiss, 
Jena, Germany) confocal laser scanning 
microscope equipped with a 40× 1.3 NA Plan-
NEOFLUAR objective (Zeiss, Jena, Germany). 
All images were deconvolved using Huygens® 
Essential (Hilversum, The Netherlands) and 
processed for contrast and brightness with ImageJ. 
 
Field emission scanning electron microscopy - 
For field emission scanning electron microscopy 
(FESEM), HUVEC were cultivated and co-
incubated with protein-coated latex beads (3 µm; 
approx. 108 beads) for 2 h at 37°C under a 
humidified environment containing 5% CO2. Cells 
were washed three times with EGM 2 basal 
medium, fixed with 5% formaldehyde and 2% 
glutaraldehyde in cacodylate buffer, and prepared 
for electron microscopic analysis as described 
(12). Images were recorded digitally with a Slow-
Scan CCD-Camera (ProScan, 1024x1024, 
Scheuring, Germany) with ITEM-Software 
(Olympus Soft Imaging Solutions, Münster, 
Germany). Brightness and contrast were adjusted 
with Adobe Photoshop CS3.  
Preparation of SpyCep-gold particles – A 
solution of colloidal gold with a particle size of 15 
nm was coupled to recombinant SpyCep using a 
coupling method as described (11). SpyCep-gold 
particles were washed three times in EGM 2 
medium and 50 µl of the gold particle solution was 
added to HUVE cells. Adherence and 
internalization of SpyCep-gold particles to and into 
HUVEC was monitored as for the SpyCep-coated 
polystyrene beads. 
Invasion inhibition experiments - For testing the 
invasion-inhibiting potential of anti-SpyCep 
antibodies, HUVEC were grown on coverslips as 
described above. On the day of infection, 
endothelial cells were washed once in EGM2 
medium containing 5% FCS. SpyCep-coated beads 
were pre-incubated with anti-SpyCep polyclonal 
rabbit IgG or non-immune rabbit IgG as control at 
a final concentration of 10 µg/ml for 1 hr. Cells 
were then co-incubated with beads and processed 
as described above. For determination of uptake 
rates, intracellular beads were differentially stained 
as described above and counted using a 
fluorescence microscope. Intracellular beads of at 
least 100 cells were determined and uptake rates 
expressed as number of intracellular beads per cell. 
Experiments were conducted in triplicate on two 
different days, data presented here resulted from 
one representative experiment. 
Quantification of SpyCep surface localization 
by flow cytometry. Streptococcal strains were 
grown to mid-exponential phase in TSB medium 
and washed once in PBS. A total of 1x107 bacteria 
was suspended in 400 µl of PBS containing 0.5% 
FCS and incubated with 0.5 µg anti-SpyCep rabbit 
IgG for 30 min at 37°C. After washing in PBS the 
bacterial pellet was suspended in 100 µl PBS 
containing a 1:300 dilution of an anti rabbit 
ALEXA Fluor 488 antibody (Invitrogen) and 
incubated for 30 min at 37°C. Bacteria were 
washed in PBS, fixed in PBS containing 3% para-
formaldehyde and analyzed by flow cytometry 
using a FACSCalibur (Becton Dickinson). 
Streptococci were detected using log-forward and 
log-side scatter dot plots, and a gating region was 
set to exclude debris and larger aggregates of 
bacteria. 104 bacteria were analyzed for 
fluorescence using log-scale amplification. For 
detection of SpyCep on latex beads, 1x107 
SpyCep-coupled beads were incubated with the 
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 respective antibodies and analyzed as described 
above. 
 
 RESULTS 
Cloning, expression and purification of 
enzymatically active SpyCep – The scpC (SpyCep 
encoding) gene encodes a 1647 amino acid 
protein with an approximate molecular mass of 
150 kDa. To be able to perform functional studies 
with this important virulence factor, we used an E. 
coli expression system to generate and purify a C-
terminal 6xHistidine (6xHis) affinity tagged 
SpyCep in its biologically active form. Western 
blotting for direct detection of the fusion protein 
protein recognized a band with the anticipated 
molecular weight of ~ 150 kDa in the cell lysate 
of E. coli transformants (Fig. 1A), indicating 
expression of mature full length rSpyCep. 
rSpyCep was purified from the bacterial cell 
lysate under native conditions by using 
immobilized Ni-NTA affinity chromatography 
(Figure 1B).  To determine the IL-8 degrading 
activity of rSpyCep, a degradation assay based on 
the quantification of IL-8 via the Quantikine kit 
was conducted. The culture supernatant of the 
invasive S. pyogenes strain A475 served as a 
positive control for IL-8 degradation and its 
isogenic SpyCep deletion mutant (A475 
∆SpyCep) was used as a negative control. As 
shown in Figure 1C, rSpyCep efficiently degraded 
IL-8, as did the culture supernatant of the WT S. 
pyogenes strain while the ∆SpyCep mutant strain 
lacked IL-8 degrading activity. The IL-8 
degrading activity of rSpyCep was further 
confirmed by Western blot analysis (Fig. 1D). 
These data demonstrate the successful cloning, 
expression, and purification of full length mature 
SpyCep in its functionally active form. 
 
Functional dissection of the domains required 
for IL-8 degrading activity – In order to 
functionally dissect the SpyCep domains 
responsible for IL-8 degradation, three derivatives 
of rSpyCep were generated based on the domain 
structure described for cell envelope serine 
proteases of lactic acid bacteria (2). Figure 2 
shows the recombinant purified subfragments of 
SpyCep. Two C-terminally truncated variants of 
the active rSpyCep were generated: PR+A, and 
PR. In addition, one N-terminally truncated 
fragment encompassing the A+B/H domain, but 
lacking the PR domain was generated. Using 
Quantikine ELISA for determination of the IL-8 
degrading activity of the purified proteins, the 
minimal region required for efficient IL-8 
degradation was demonstrated to be PR+A (Fig. 
2B). Neither the PR domain alone, predicted to 
harbour the catalytic triad of the serine protease, 
nor the A+B/H domain were able to cleave IL-8.   
 
SpyCep mediates specific uptake into primary 
human endothelial cells – SpyCep is most likely 
expressed during soft tissue infection as 
demonstrated by a reduction of chemokines in 
infected tissue (4). We thus aimed to analyze 
potential direct interactions of SpyCep with 
eukaryotic cells of human origin. Since S. 
pyogenes expresses a diverse array of adhesive and 
invasive factors on its surface, we adopted a latex 
bead adherence/internalization assay to allow 
analysis of recombinant SpyCep polypeptides in 
isolation. Latex beads coated with rSpyCep did not 
show any adherence or internalization potential on 
either pharynx (HEp2) or lung (A549) epithelial 
cells (data not shown). However, in contrast to the 
epithelial cell findings, rSpyCep-coated beads 
efficiently attached to and became internalized into 
primary human endothelial cells (HUVEC) within 
two hours of co-incubation (Fig. 3A). 
Internalization was observed to be very efficient in 
some cells, with up to 40 internalized beads per 
cell, but we simultaneously observed completely 
empty cells, leading to a mean internalization rate 
of 32 beads per 10 cells. Next, we aimed to 
identifying the internalization-mediating domain of 
SpyCep. The recombinant PR polypeptide, 
representing the N-terminal part of SpyCep, and 
the A+B/H polypeptide, representing the residual 
C-terminal part of SpyCep, were tested for 
internalization-mediating activity in the latex bead 
assay. Quantification of internalization rates 
revealed that the PR-domain of SpyCep was 
sufficient to mediate internalization into 
endothelial cells, whereas the residual part of 
SpyCep did not stimulate internalization beyond 
background control levels (Fig. 3B). 
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 Ultrastructural analysis by electron microcopy 
revealed that SpyCep stimulated the formation of 
membrane protrusions on the endothelial cell 
surface (Fig. 4A-D). On the cytoskeletal level, 
SpyCep-coated beads induced the formation of F-
actin rich structures engulfing the beads (Fig. 4E-
F, Arrows). These results demonstrate that 
SpyCep mediates an endothelial cell specific 
uptake and that the N-terminal PR domain is both 
essential and sufficient for triggering uptake, 
although it lacks IL-8 degrading activity. 
 
SpyCep-mediated uptake follows an endocytic 
pathway – S. pyogenes triggers an endocytic 
pathway that efficiently delivers invasive M3 
streptococci into lysosomes (13) of endothelial 
cells. Thus, to identify the route of internalization 
and destination of SpyCep-mediated uptake, we 
tested whether SpyCep-coated beads also follow 
the classical endocytic pathway. Immunostainings 
of beads and the early endosomal marker EEA1 
and the late endosomal/lysosomal marker protein 
Lamp-1 were conducted at early (60 min) and 
later stages (120 min) of co-incubation. 
Immunofluorescence microscopic analysis 
revealed the presence of internalized SpyCep-
beads in an EEA1 positive compartment at early 
time points (Fig. 5A, arrow). After 120 min of 
incubation, the majority of beads were found to be 
localized in a Lamp-1 positive compartment (Fig. 
5B). Since the 3 µm bead size itself may influence 
the sorting direction of the beads, SpyCep was 
coupled to 15 nm gold particles revealing a 
pseudo-soluble fraction of SpyCep. This pseudo-
soluble form of the protein allowed to visualize 
uptake and trafficking of SpyCep in HUVEC. As 
for the SpyCep-beads, SpyCep-gold particles were 
efficiently taken up into HUVEC and delivered to 
lysosomes (Fig. 5C-E). Within lysosomes, gold 
particles did no more react with the anti-SpyCep 
antibody, revealing the loss of antigenicity or 
dissociation of SpyCep within lysosomes. This 
indicates that SpyCep mediates its uptake and 
subsequent trafficking via the classical endocytic 
pathway with lysosomal destination.  
SpyCep does not act as invasin on the bacterial 
surface – In order to address the question whether 
SpyCep may act as invasin on the streptococcal 
surface, we constructed a SpyCep hyper-
expressing S. agalactiae strain by transforming it 
with the previously described plasmid pCepA (5). 
Flow cytometry analysis was conducted to quantify 
the amount of surface located SpyCep on the 
constructed strain, as well as on the GBS control 
strain. As shown in Fig S1, SpyCep expressing S. 
agalactiae (GBS-SpyCep) showed a 50 fold 
stronger fluorescent signal compared to the M3 S. 
pyogenes strain A475, and a more than 100 fold 
increase in fluorescence compared to the GBS 
control strain (GBSpDCerm). This result 
demonstrates that the GBS-SpyCep construct is a 
hyper-expressing strain with an even higher 
content of surface associated SpyCep than the M3 
S. pyogenes strain. However, in contrast to the M3 
S. pyogenes strain, GBS-SpyCep showed no 
invasion activity on HUVEC (data not shown). 
Moreover, analysis of the invasion potential of the 
SpyCep knockout A475 S. pyogenes strain 
revealed an equal uptake rate as compared to the 
A475 wildtype strain (data not shown). Thus, it 
may be concluded that SpyCep does not act as 
invasin on the streptococcal surface. 
A blocking antibody for SpyCep-mediated 
internalization – Purified anti-rSpyCep IgG or 
non-immune rabbit IgG were added to rSpyCep-
coated beads prior to co-incubation with HUVEC. 
Only SpyCep-specific antibodies significantly 
blocked internalization of beads into HUVEC, but 
not the control rabbit IgG antibodies (Fig. 6). 
When anti-SpyCep antibodies were tested for their 
ability to interfere with the IL-8 degrading activity 
of SpyCep, the antibodies had no effect (data not 
shown), further strengthening the concept that 
cellular interaction and IL-8 degradation are two 
distinct functions displayed by this important 
virulence factor of S. pyogenes. 
 
DISCUSSION 
S. pyogenes is a strict human pathogen in which 
a variety of multifunctional virulence factors have 
evolved. For example, C5a peptidase, structurally 
related to SpyCep, is a multifunctional S. pyogenes 
surface protease, shown to possess C5a-degrading 
activity but also adhesive functions, independent 
from the enzymatic activity (14). In the present 
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 case of SpyCep, only one biochemical function 
had been previously recognized: the ability to 
specifically bind and cleave CXC chemokines, 
one of which is IL-8. In published animal studies, 
a clear consequence of SpyCep expression has 
been improved survival and greater tissue 
spreading of the bacteria during the course of 
necrotizing soft tissue infection (3, 4, and 5). We 
here demonstrate cloning, expression and 
purification of full length mature SpyCep in its 
enzymatically active form. This polypeptide 
served as starting molecule for designing further 
C- and N-terminal truncations that allowed 
defining the minimal domain required for IL-8 
degradation. A recent study also attempted to 
express active recombinant SpyCep (15); 
however, recombinant enzymatic activity was 
only obtained by combining two recombinant 
subfragments of SpyCep. This is in contrast to our 
findings, as confirmed both by quantitative IL-8 
degradation assay and western blot analysis, that 
full length mature SpyCep (excluding the 
predicted pre-pro domain) was enzymatically 
active being expressed as one polypeptide (Fig. 
1). Furthermore, the C-terminally truncated 
subfragment (PR+A, lacking 521 amino acid 
residues of the C-terminus as well as the pre-pro 
domain) was sufficient to cleave IL-8 (Fig. 2, Fig. 
7). These data further characterize the chemokine 
degrading function of SpyCep. 
The human endothelium is an important 
cellular barrier through which IL-8 is transported, 
and on which it becomes exposed through binding 
to glucosaminoglycans to function in leukocyte 
recruitment (16, 17, 18). Here we analyzed the 
invasion activity of SpyCep using a latex bead-
based internalization assay, which previously led 
to the discovery of many potent bacterial invasins 
19, 20, 21, and 22), as well as pseudo-soluble 
SpyCep coupled to 15 nm gold particles. The 
results demonstrate that SpyCep specifically 
mediates its own uptake into endothelial cells via 
an endosomal pathway, and that the PR domain is 
required but also sufficient to mediate cell entry 
(Fig. 5 and 7). The question arises whether 
SpyCep is an ivasin. Our results indicate that 
SpyCep, expressed on the surface of GBS, does not 
mediate streptococcal invasion. Moreover, 
inactivation of the SpyCep-encoding gene in M3 S. 
pyogenes had no effect on the invasion potential. 
To fulfill the function of an invasin, SpyCep has to 
be surface exposed and covalently linked to the 
streptococcal cell. However, secreted derivatives 
of SpyCep lack the C-terminal part of the protein 
(3), indicating post-translational processing events 
that may be responsible for the loss of the N-
terminal invasion- mediating PR domain in its 
surface anchored form.  Moreover, a very recent 
publication demonstrated that SpyCep is auto-
catalytically processing its N-terminus, leading to 
the generation of an N-terminal cleavage product 
that non-covalently assembles to the C-terminal 
part and assembles to an active protease (23). 
Interestingly, the cleavage side resides within the 
PR domain between residue 244 and 245, 
demonstrating that the N-terminal part of the PR 
domain is no more covalently linked to the 
peptidoglycan. These findings may thus explain 
why SpyCep does not act as invasin, even if it is 
hyper-expressed in the GBS system. Our 
interpretation is that SpyCep is potent in mediating 
its own internalization into HUVEC but may not 
be considered as invasin of S. pyogenes.  
One key observation was that SpyCep impairs 
neutrophil recruitment from blood stream to the 
tissue site of infection by inactivating IL-8 (3, 4, 5, 
and 24). IL-8 produced by extravascular cells 
(macrophages, fibroblasts) must traverse the EC 
barrier from tissue site of infection to the luminal 
side of the endothelium in order to exert its 
proemigratory effect on neutrophils (16). SpyCep 
produced at the tissue site may efficiently degrade 
IL-8 locally, and thus prevent EC transcytosis and 
luminal presentation. However, EC are also able to 
produce and secrete endogenous IL-8. This EC IL-
8 will not be exposed to the tissue site but directly 
transported to and presented at the luminal side of 
the EC barrier. Thus, the ability of SpyCep to 
promote its specific uptake into EC may represent 
a key event for interaction of SpyCep with EC 
derived IL-8 or the endothelial barrier itself. 
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FIGURE LEGENDS 
 
Fig. 1. Cloning and recombinant expression of functionally active SpyCep  A) E. coli cells transformed 
with pQE60 derivative expressing full length mature rSpyCep were induced with IPTG, lyzed,  and 
separated via SDS-PAGE. Following transfer to a nitrocellulose membrane rSpyCep was visualized using 
a Ni-NTA horseradish peroxidase conjugate for direct detection of the histidine tag. B) SDS-PAGE 
analysis of the E. coli cell lysate showing the expression of rSpyCep with molecular weight of 
approximately 120-150 kDa. Lanes 1-6 refer to the fractions collected after purification of rSpyCep from 
bacterial crude extracts using Ni-NTA agarose. C) Quantitative IL-8 degradation assay using the human 
IL-8 Quantikine ELISA kit. Uncleaved IL-8 and IL-8 incubated with the culture supernatant of the 
SpyCep knock out mutant of strain A475 served as negative control, whereas incubation of IL-8 with the 
supernatant of the S. pyogenes WT strain A475 served as positive control for IL-8 cleavage. 5 ng of 
rSpyCep were capable of degrading IL-8. The graph shows mean values of three independent 
experiments. D) Visualization of  rSpyCep mediated IL-8 degradation by Western blot analysis using an 
anti-human IL-8 monoclonal antibody that recognizes only full length IL-8. S. pyogenes JS95 culture 
supernatant served a positive control. Graph represents mean ± SD. 
 
Fig. 2. Recombinant expression and functional dissection of SpyCep subdomains. A) Coomassie stained 
SDS-PAGE after expression and purification of PR+A, PR, and A+B/H domain of SpyCep. B) IL-8 
degrading activity of rSpyCep and its subdomains as determined by IL8-Quantikine ELISA. Graph 
represents mean ± SD. 
 
Fig. 3. SpyCep mediates internalization of SpyCep-coated beads into HUVEC. A) Confocal maximum 
intensity projection of a double immuno-fluorescence staining of HUVEC with extra-cellular attached 
(green) and intra-cellular (red) SpyCep-coated beads and the corresponding phase contrast image. Note 
that a substantial number of internalized beads are no more stained by the anti SpyCep antibody 
indicating loss of SpyCep and thus are only visible in the phase contrast image. Bar represents 10 µm. B) 
Comparison of bead internalization rates into HUVEC. SpyCep-coated beads served as positive control, 
GST-coated beads as negative control. Graph represents mean ± SD. 
 
Fig. 4. SpyCep induces cytoskeletal rearrangements during uptake. Scanning electron microscopic image 
of SpyCep-coated beads being internalized into HUVEC (A-D). Extra-cellular beads are taken up by a 
zipper-like mechanism characterized by formation of membrane protrusions. Bars represent 2 µm. 
Confocal maximum intensity projection of SpyCep-coated beads that show accumulation of F-actin (E) 
and the corresponding phase contrast image (F). Bar represents 10 µm. 
 
Fig. 5. SpyCep mediates uptake via the classical endocytic pathway. A) Accumulation of early endosomal 
antigen 1 (EEA1) in the vicinity of rSpyCep-coated internalized latex beads (arrow). B)  Internalized 
beads are delivered to Lamp-1 positive compartments. Arrows exemplify Lamp-1 accumulation around 
beads, whereas arrowheads point to beads within non-maturated phagosomal compartments. Single 
confocal sections are shown. Bars represent 10 µm. C) Internalization of pseudo-soluble SpyCep-gold 
into HUVEC (extracellular SpyCep-gold is green, intracellular red). The right panel shows phase contrast 
image (white arrow shows extracellular gold particle, black arrow intracellular gold; reactivity with the 
anti-SpyCep antibody). D)  Lamp-1 stain of SpyCep-gold particles in HUVEC (black arrows show 
internalized SpyCep-gold particles, asterisks indicate gold particles within lysosomes that lost anti-
SpyCep reactivity. E) Scanning EM of SpyCep gold particles internalized by HUVEC. At low voltage (2 
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 kV, left panel) extracellular gold particles appear brighter (white arrow) than intracellular gold particles 
(arrowheads). At higher voltage (15 kV, right panel), the insert shows single internalized gold particles at 
higher resolution. Bars represent 5 µm. 
 
Fig. 6. Inhibition of invasion of rSpyCep-coated latex beads into HUVEC by anti-SpyCep antibodies. 
SpyCep-beads were first pre-incubated with rabbit polyclonal anti-SpyCep antibodies for 1 h and then co-
incubated with HUVEC for 2 h. Pre-incubation of SpyCep-coated beads with anti-SpyCep IgG 
completely abolished the adherence to and invasion of SpyCep-coated beads into HUVEC. Non-immune 
rabbit IgG served as control. Graph represents mean ± SD. 
 
Fig. 7. Schematic overview of the domain structure of SpyCep . The recombinant SpyCep fusion peptides 
generated in this work and their IL-8 degrading and endothelial cell invasion activity are displayed. 
Amino acid residue positions are given for each fragment (according to accession no. ABA33824.1) 
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